Search Results
Search for other papers by Lingyun Lu in
Google Scholar
PubMed
Search for other papers by Li Tian in
Google Scholar
PubMed
( Li et al. 2021 ). Osteoporosis and sarcopenia are common public health problems that tend to coexist in older individuals. A syndrome termed ‘osteosarcopenia’ was previously described ( Clynes et al. 2021 ), in which there is a strong link between
Search for other papers by Lina Lawenius in
Google Scholar
PubMed
Search for other papers by Hannah Colldén in
Google Scholar
PubMed
Search for other papers by Karin Horkeby in
Google Scholar
PubMed
Search for other papers by Jianyao Wu in
Google Scholar
PubMed
Search for other papers by Louise Grahnemo in
Google Scholar
PubMed
Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia
Search for other papers by Liesbeth Vandenput in
Google Scholar
PubMed
Search for other papers by Claes Ohlsson in
Google Scholar
PubMed
Search for other papers by Klara Sjögren in
Google Scholar
PubMed
Introduction Osteoporosis is a debilitating disease affecting one in two women and one in five men after 50 years of age ( Sambrook & Cooper 2006 ). Both men and women lose bone in an age-dependent manner because of decreasing sex hormone
Search for other papers by Louise Grahnemo in
Google Scholar
PubMed
Departments of Rheumatology and Inflammation Research, Internal Medicine and Clinical Nutrition, Laboratory of Tumor Immunology and Biology, Centre for Bone and Arthritis Research, Institute of Medicine, The Sahlgrenska Academy, University of Gothenburg, Box 480, Gothenburg 405 30, Sweden
Search for other papers by Caroline Jochems in
Google Scholar
PubMed
Search for other papers by Annica Andersson in
Google Scholar
PubMed
Departments of Rheumatology and Inflammation Research, Internal Medicine and Clinical Nutrition, Laboratory of Tumor Immunology and Biology, Centre for Bone and Arthritis Research, Institute of Medicine, The Sahlgrenska Academy, University of Gothenburg, Box 480, Gothenburg 405 30, Sweden
Search for other papers by Cecilia Engdahl in
Google Scholar
PubMed
Search for other papers by Claes Ohlsson in
Google Scholar
PubMed
Search for other papers by Ulrika Islander in
Google Scholar
PubMed
Search for other papers by Hans Carlsten in
Google Scholar
PubMed
without glucocorticoid treatment, these women have a high risk of developing osteoporosis; approximately 20% of women in Europe over 50 years of age are affected by postmenopausal osteoporosis. The lifetime fracture risk in these women is over 45
Search for other papers by Bernard Freudenthal in
Google Scholar
PubMed
Search for other papers by John Logan in
Google Scholar
PubMed
Search for other papers by Sanger Institute Mouse Pipelines in
Google Scholar
PubMed
Search for other papers by Peter I Croucher in
Google Scholar
PubMed
Search for other papers by Graham R Williams in
Google Scholar
PubMed
Search for other papers by J H Duncan Bassett in
Google Scholar
PubMed
Introduction A novel strategy for osteoporosis gene discovery Studies of human monogenic extreme phenotype disorders have been instrumental in discovering genetic and molecular mechanisms of common diseases including obesity and diabetes
Search for other papers by Qin Yin in
Google Scholar
PubMed
Search for other papers by Jun Gu in
Google Scholar
PubMed
Search for other papers by Pengju Ren in
Google Scholar
PubMed
Search for other papers by Zhiqiang Guan in
Google Scholar
PubMed
Department of Orthopedics, Northern Jiangsu People’s Hospital, Yangzhou, China
Search for other papers by Yongxiang Wang in
Google Scholar
PubMed
Search for other papers by Ruijun Bai in
Google Scholar
PubMed
Search for other papers by Yu Liu in
Google Scholar
PubMed
Introduction Osteoarthritis (OA) and osteoporosis (OP) are prevalent musculoskeletal disorders that contribute to disability in the elderly ( Oliveira et al. 2020 ). Numerous studies have predicted a seven-fold increase in the incidence of
Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh, India
Search for other papers by Sonu Khanka in
Google Scholar
PubMed
Search for other papers by Charul Somani in
Google Scholar
PubMed
Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh, India
Search for other papers by Kriti Sharma in
Google Scholar
PubMed
Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh, India
Search for other papers by Shivani Sharma in
Google Scholar
PubMed
Sophisticated Analytical Instrument Facility & Research, Division, CSIR-Central Drug Research Institute, Lucknow, India
Search for other papers by Akhilesh Kumar in
Google Scholar
PubMed
Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh, India
Search for other papers by Naibedya Chattopadhyay in
Google Scholar
PubMed
Sophisticated Analytical Instrument Facility & Research, Division, CSIR-Central Drug Research Institute, Lucknow, India
Search for other papers by Sanjeev K Kanojiya in
Google Scholar
PubMed
Search for other papers by Dinesh Kumar Yadav in
Google Scholar
PubMed
Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh, India
Search for other papers by Divya Singh in
Google Scholar
PubMed
Introduction Osteoporosis is a major medical and socioeconomic problem among elderly people, particularly affecting postmenopausal women. Impaired bone mass, strength and deterioration of bone microarchitecture are consequences associated with
Search for other papers by Wang Xiao in
Google Scholar
PubMed
Search for other papers by Fei Beibei in
Google Scholar
PubMed
Search for other papers by Shen Guangsi in
Google Scholar
PubMed
Search for other papers by Jiang Yu in
Google Scholar
PubMed
Search for other papers by Zhang Wen in
Google Scholar
PubMed
Search for other papers by Huang Xi in
Google Scholar
PubMed
Search for other papers by Xu Youjia in
Google Scholar
PubMed
Introduction Primary type I osteoporosis, also known as postmenopausal osteoporosis (PMO), is a bone disease associated with reduced bone mineral density, disordered bone architecture and increased fragility ( Chinese Orthopaedic Association 2009
Center for Health Disparities and Molecular Medicine, School of Medicine, Loma Linda University, Loma Linda, California, USA
Division of Biochemistry, Department of Basic Sciences, School of Medicine, Loma Linda University, Loma Linda, California, USA
Search for other papers by Richard C Lindsey in
Google Scholar
PubMed
Search for other papers by Catrina Godwin in
Google Scholar
PubMed
Center for Health Disparities and Molecular Medicine, School of Medicine, Loma Linda University, Loma Linda, California, USA
Division of Biochemistry, Department of Basic Sciences, School of Medicine, Loma Linda University, Loma Linda, California, USA
Department of Medicine, School of Medicine, Loma Linda University, Loma Linda, California, USA
Department of Orthopedics, School of Medicine, Loma Linda University, Loma Linda, California, USA
Search for other papers by Subburaman Mohan in
Google Scholar
PubMed
Introduction Osteoporosis, a debilitating condition in which an increase in bone resorption is not adequately compensated by a corresponding increase in bone formation, leading to net loss of bone mass and microarchitectural deterioration
Search for other papers by Claire L Wood in
Google Scholar
PubMed
Department of Women’s and Children’s Health, Karolinska Institutet and Pediatric Endocrinology Unit, Karolinska University Hospital, Stockholm, Sweden
Search for other papers by Ondrej Soucek in
Google Scholar
PubMed
Search for other papers by Sze C Wong in
Google Scholar
PubMed
Search for other papers by Farasat Zaman in
Google Scholar
PubMed
Search for other papers by Colin Farquharson in
Google Scholar
PubMed
Search for other papers by Lars Savendahl in
Google Scholar
PubMed
Search for other papers by S Faisal Ahmed in
Google Scholar
PubMed
-induced osteoporosis (GIO) and growth retardation. Osteoporosis is characterized by a reduction in bone mass and loss of bone microarchitecture, leading to impaired bone strength and increased fracture risk ( Reinwald & Burr 2008 ). GIO is the most prevalent type of
Academy of Scientific and Innovative Research (AcSIR), Ghaziabad-201002, India
Search for other papers by Alok Tripathi in
Google Scholar
PubMed
Division of Medicinal & Process Chemistry, CSIR-Central Drug Research Institute, Lucknow, 226031, India
Search for other papers by Pallavi Awasthi in
Google Scholar
PubMed
Division of Medicinal & Process Chemistry, CSIR-Central Drug Research Institute, Lucknow, 226031, India
Search for other papers by Kundan Singh Rawat in
Google Scholar
PubMed
Search for other papers by Atma P Dwivedi in
Google Scholar
PubMed
Academy of Scientific and Innovative Research (AcSIR), Ghaziabad-201002, India
Search for other papers by Krishna Bhan Singh in
Google Scholar
PubMed
Academy of Scientific and Innovative Research (AcSIR), Ghaziabad-201002, India
Search for other papers by Kriti Sharma in
Google Scholar
PubMed
Search for other papers by Ravi Prakash in
Google Scholar
PubMed
Academy of Scientific and Innovative Research (AcSIR), Ghaziabad-201002, India
Search for other papers by Divya Singh in
Google Scholar
PubMed
Division of Medicinal & Process Chemistry, CSIR-Central Drug Research Institute, Lucknow, 226031, India
Search for other papers by Atul Goel in
Google Scholar
PubMed
Introduction Fracture caused by osteoporosis is increasingly becoming a global public health problem ( Compston et al . 2019 ). In the United States alone, each year, there are approximately 1.5 million fractures including hip fractures and